Last reviewed · How we verify

Biological: GC3111 vaccine

Green Cross Corporation · Phase 1 active Biologic

Biological: GC3111 vaccine is a Biologic drug developed by Green Cross Corporation. It is currently in Phase 1 development. Also known as: GC3111.

At a glance

Generic nameBiological: GC3111 vaccine
Also known asGC3111
SponsorGreen Cross Corporation
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Biological: GC3111 vaccine

What is Biological: GC3111 vaccine?

Biological: GC3111 vaccine is a Biologic drug developed by Green Cross Corporation.

Who makes Biological: GC3111 vaccine?

Biological: GC3111 vaccine is developed by Green Cross Corporation (see full Green Cross Corporation pipeline at /company/green-cross-corporation).

Is Biological: GC3111 vaccine also known as anything else?

Biological: GC3111 vaccine is also known as GC3111.

What development phase is Biological: GC3111 vaccine in?

Biological: GC3111 vaccine is in Phase 1.

Related